WHO Reviewing US' Moderna COVID-19 Vaccine For Emergency Listing

The WHO on April 26 said it is reviewing US’ Moderna COVID-19 vaccine for emergency use listing. Being reviewed at the Technical Advisory Group meeting, the WHO spokesperson Christian Lindmeier said the decision will be revealed within next four days. Vaccines developed by Pfizer, AstraZeneca, and Johnson & Johnson have already received WHO’s approval. Notably, the vaccines are ready to be used once approved by the national regulatory bodies.